Functionally, the suppression of PD‐L1 expression in DA‐treated MDA‐MB‐231 cells led to reduced PD1 protein binding to cancer cells and enhanced killing of activated T cells against cancer cells, indicating an inhibition of PD‐L1 and tumour immune evasion by DA. The gene discussed is CD274; the disease is neoplasm.